EAM Investors, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$1,389,000
-8.2%
218,429
-31.6%
0.22%
-13.1%
Q1 2018$1,513,000
-39.0%
319,187
+97.1%
0.25%
-43.6%
Q1 2014$2,479,000
+62.7%
161,935
+5.9%
0.45%
+47.0%
Q3 2013$1,524,000152,8540.30%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders